相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen)
Martyn Frederickson et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach
Sitthivut Charoensutthivarakul et al.
ACS INFECTIOUS DISEASES (2022)
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
Luca G. Mureddu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design
Sherine E. Thomas et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Structural and Mechanistic Insights into Mycobacterium abscessus Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived Inhibitor
Wuan-Geok Saw et al.
ACS INFECTIOUS DISEASES (2022)
Genome-Wide Study of Drug Resistant Mycobacterium tuberculosis and Its Intra-Host Evolution during Treatment
Denis Lagutkin et al.
MICROORGANISMS (2022)
Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases
Yann Ayotte et al.
ACS CHEMICAL BIOLOGY (2021)
Phosphopantetheine Adenylyltransferase: A promising drug target to combat antibiotic resistance
Akshita Gupta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2021)
The M. tuberculosis Rv1523 Methyltransferase Promotes Drug Resistance Through Methylation-Mediated Cell Wall Remodeling and Modulates Macrophages Immune Responses
Sabeeha Ali et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Mycobacterium tuberculosis PanD Structure-Function Analysis and Identification of a Potent Pyrazinoic Acid-Derived Enzyme Inhibitor
Priya Ragunathan et al.
ACS CHEMICAL BIOLOGY (2021)
Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
Shan Zhou et al.
ELIFE (2021)
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
Sangmi Oh et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Fragment-Based Drug Discovery for RNA Targets
Kasper P. Lundquist et al.
CHEMMEDCHEM (2021)
Design of Novel Phosphopantetheine Adenylyltransferase Inhibitors: A Potential New Approach to Tackle Mycobacterium tuberculosis
Marina C. Primi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
Role of Glutathione in Chalcone Derivative Induced Apoptosis ofBrugia malayiand its Possible Therapeutic Implication
P. S. Bhoj et al.
ACTA PARASITOLOGICA (2021)
Fragment-based drug discovery using cryo-EM
Michael Saur et al.
DRUG DISCOVERY TODAY (2020)
Protein X-ray Crystallography and Drug Discovery
Laurent Maveyraud et al.
MOLECULES (2020)
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
Lauro Ribeiro de Souza Neto et al.
FRONTIERS IN CHEMISTRY (2020)
Structure-Based Design and Synthesis of Piperidinol-Containing Molecules as New Mycobacterium abscessus Inhibitors
Jerome de Ruyck et al.
CHEMISTRYOPEN (2020)
Application of Fragment-Based Drug Discovery to Versatile Targets
Qingxin Li
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification
Sherine E. Thomas et al.
NUCLEIC ACIDS RESEARCH (2020)
Homology modeling in drug discovery: Overview, current applications, and future perspectives
Muhammed Tilahun Muhammed et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
A bright future for fragment-based drug discovery: what does it hold?
Celien Jacquemard et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
The Light and Dark Sides of Virtual Screening: What Is There to Know?
Aleix Gimeno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis
Catherine Vilcheze et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors
Wenhe Zhong et al.
ACS INFECTIOUS DISEASES (2019)
Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches
Andrew J. Whitehouse et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping
Sherine E. Thomas et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2019)
Concepts and Core Principles of Fragment-Based Drug Design
Philine Kirsch et al.
MOLECULES (2019)
Fragment-based approaches to TB drugs
Chiara Marchetti et al.
PARASITOLOGY (2018)
NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening
Christopher C. Thornburg et al.
ACS CHEMICAL BIOLOGY (2018)
Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity
Michael B. Harbut et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis
Bei Shi Lee et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
NTM drug discovery: status, gaps and the way forward
Mu-Lu Wu et al.
DRUG DISCOVERY TODAY (2018)
Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors
Prasanthi Malapati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
Simon Tiberi et al.
LANCET INFECTIOUS DISEASES (2018)
NMR-Fragment Based Virtual Screening: A Brief Overview
Meenakshi Singh et al.
MOLECULES (2018)
MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
Wei Li et al.
FRONTIERS IN MICROBIOLOGY (2018)
Mechanism of Action of Mycobacterium tuberculosis Gyrase Inhibitors: A Novel Class of Gyrase Poisons
Elizabeth G. Gibson et al.
ACS INFECTIOUS DISEASES (2018)
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
Dinakaran Murugesan et al.
ACS INFECTIOUS DISEASES (2018)
Using Fragment-Based Approaches to Discover New Antibiotics
Bas Lamoree et al.
SLAS DISCOVERY (2018)
Anion-pi Interactions in Computer-Aided Drug Design: Modeling the Inhibition of Malate Synthase by Phenyl-Diketo Acids
Jill F. Ellenbarger et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis
Sangeeta Tiwari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
Jimyung Park et al.
CLINICAL INFECTIOUS DISEASES (2017)
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
Vinayak Singh et al.
ACS INFECTIOUS DISEASES (2017)
Fragment Database FDB-17
Ricardo Visini et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Structural Biology and the Design of New Therapeutics: From HIV and Cancer to Mycobacterial Infections A Paper Dedicated to John Kendrew
Sherine E. Thomas et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Advances in the field of single-particle cryo-electron microscopy over the last decade
Joachim Frank
NATURE PROTOCOLS (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Genomic Comparisons Reveal Microevolutionary Differences in Mycobacterium abscessus Subspecies
Joon L. Tan et al.
FRONTIERS IN MICROBIOLOGY (2017)
Identification of unique essential proteins from a Mycobacterium tuberculosis F15/LAM4/KZN phage secretome library
Thamsanqa Emmanuel Chiliza et al.
PATHOGENS AND DISEASE (2017)
Tools for ligand validation in Coot
Paul Emsley
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)
Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish
Christian Dupont et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
Petar O. Nikiforov et al.
ACS CHEMICAL BIOLOGY (2017)
A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring
Jonathan Cramer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
Substrate independent ATPase activity may complicate high throughput screening
Micheal L. Tuntland et al.
ANALYTICAL BIOCHEMISTRY (2016)
New and Old Hot Drug Targets in Tuberculosis
Laurent Roberto Chiarelli et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Developments in SPR Fragment Screening
Alain Chavanieu et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Mycobacterium tuberculosis Malate Synthase Structures with Fragments Reveal a Portal for Substrate/Product Exchange
Hsiao-Ling Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
Gyoergy M. Keseru et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
Madeline E. Kavanagh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination
Lucy A. Woods et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Christian Dupont et al.
MOLECULAR MICROBIOLOGY (2016)
Native Mass Spectrometry in Fragment-Based Drug Discovery
Liliana Pedro et al.
MOLECULES (2016)
Toxin-antitoxin systems in bacterial growth arrest and persistence
Rebecca Page et al.
NATURE CHEMICAL BIOLOGY (2016)
Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
tRNA-mediated codon-biased translation in mycobacterial hypoxic persistence
Yok Hian Chionh et al.
NATURE COMMUNICATIONS (2016)
Identification of KasA as the cellular target of an anti-tubercular scaffold
Katherine A. Abrahams et al.
NATURE COMMUNICATIONS (2016)
Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen
Jonathan A. G. Cox et al.
SCIENTIFIC REPORTS (2016)
Fragment-Based Whole Cell Screen Delivers Hits against M-tuberculosis and Non-tuberculous Mycobacteria
Wilfried Moreira et al.
FRONTIERS IN MICROBIOLOGY (2016)
Prediction of Drug Penetration in Tuberculosis Lesions
Jansy P. Sarathy et al.
ACS INFECTIOUS DISEASES (2016)
Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
Julie V. Philley et al.
CHEST (2015)
Macrophage defense mechanisms against intracellular bacteria
Guenter Weiss et al.
IMMUNOLOGICAL REVIEWS (2015)
Support from Phylogenomic Networks and Subspecies Signatures for Separation of Mycobacterium massiliense from Mycobacterium bolletii
Joon Liang Tan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics
Craig S. Schneider et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Catalytic pathway, substrate binding and stability in SAICAR synthetase: A structure and molecular dynamics study
Kavyashree Manjunath et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
Protein structure prediction provides comparable performance to crystallographic structures in docking-based virtual screening
Hongying Du et al.
METHODS (2015)
Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
Magdalena Makowska-Grzyska et al.
PLOS ONE (2015)
Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis
Michael Berney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
2.2 Å resolution cryo-EM structure of β-galactosidase in complex with a cell-permeant inhibitor
Alberto Bartesaghi et al.
SCIENCE (2015)
Structure Guided Lead Generation for M. tuberculosis Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors
Maruti Naik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Inhibition of Mycobacterium tuberculosis Transaminase BioA by Aryl Hydrazines and Hydrazides
Ran Dai et al.
CHEMBIOCHEM (2014)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov et al.
EMBO MOLECULAR MEDICINE (2014)
tRNA modifications regulate translation during cellular stress
Chen Gu et al.
FEBS LETTERS (2014)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The ChEMBL bioactivity database: an update
A. Patricia Bento et al.
NUCLEIC ACIDS RESEARCH (2014)
Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential
Siew Woh Choo et al.
SCIENTIFIC REPORTS (2014)
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities
Catherine Vilcheze et al.
MICROBIOLOGY SPECTRUM (2014)
Plasmodium Gametocyte Inhibition Identified from a Natural-Product-Based Fragment Library
Hoan Vu et al.
ACS CHEMICAL BIOLOGY (2013)
Natural products: A continuing source of novel drug leads
Gordon M. Cragg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
Lluis Ballell et al.
CHEMMEDCHEM (2013)
Overcoming the Limitations of Fragment Merging: Rescuing a Strained Merged Fragment Series Targeting Mycobacterium tuberculosis CYP121
Sean A. Hudson et al.
CHEMMEDCHEM (2013)
Structural Basis for the Recognition of Mycolic Acid Precursors by KasA, a Condensing Enzyme and Drug Target from Mycobacterium Tuberculosis
Johannes Schiebel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis
Pravin S. Shirude et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Structure and Substrate-Induced Conformational Changes of the Secondary Citrate/Sodium Symporter CitS Revealed by Electron Crystallography
Fabian Kebbel et al.
STRUCTURE (2013)
Application of Fragment Screening and Merging to the Discovery of Inhibitors of the Mycobacterium tuberculosis Cytochrome P450 CYP121
Sean A. Hudson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Fragment-Based Approaches in Drug Discovery and Chemical Biology
Duncan E. Scott et al.
BIOCHEMISTRY (2012)
Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening
Garth L. Abrahams et al.
CHEMISTRY & BIOLOGY (2012)
Structure-Guided Discovery of Phenyl-diketo Acids as Potent Inhibitors of M. tuberculosis Malate Synthase
Irma V. Krieger et al.
CHEMISTRY & BIOLOGY (2012)
Fragment-Based Screening by Protein Crystallography: Successes and Pitfalls
Zorik Chilingaryan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis
Marion Flipo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of Novel Mt-Guab2 Inhibitor Series Active against M. tuberculosis
Veeraraghavan Usha et al.
PLOS ONE (2012)
Experiences in fragment-based drug discovery
Christopher W. Murray et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Identification of novel diphenyl urea inhibitors of Mt-GuaB2 active against Mycobacterium tuberculosis
Veeraraghavan Usha et al.
MICROBIOLOGY-SGM (2011)
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox et al.
NUCLEIC ACIDS RESEARCH (2011)
Novel targets in M. tuberculosis: search for new drugs
Gyanu Lamichhane
TRENDS IN MOLECULAR MEDICINE (2011)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
In silico fragment-based drug design
Zenon D. Konteatis
EXPERT OPINION ON DRUG DISCOVERY (2010)
Native MS: an 'ESI' way to support structure- and fragment-based drug discovery
Valerie Vivat Hannah et al.
FUTURE MEDICINAL CHEMISTRY (2010)
Optimization of the Interligand Overhauser Effect for Fragment Linking: Application to Inhibitor Discovery against Mycobacterium tuberculosis Pantothenate Synthetase
Pawel Sledz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Application of Fragment Growing and Fragment Linking to the Discovery of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase
Alvin W. Hung et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Targeting HSP90 for cancer therapy
D. Mahalingam et al.
BRITISH JOURNAL OF CANCER (2009)
Structural and Biophysical Characterization of XIAP BIR3 G306E Mutant: Insights in Protein Dynamics and Application for Fragment-Based Drug Design
Cathy D. Moore et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Homology modeling in drug discovery: current trends and applications
Claudio N. Cavasotto et al.
DRUG DISCOVERY TODAY (2009)
Challenges of fragment screening
Diane Joseph-McCarthy
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
The rise of fragment-based drug discovery
Christopher W. Murray et al.
NATURE CHEMISTRY (2009)
Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus
Fabienne Ripoll et al.
PLOS ONE (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
Comprehensive Functional Analysis of Mycobacterium tuberculosis Toxin-Antitoxin Systems: Implications for Pathogenesis, Stress Responses, and Evolution
Holly R. Ramage et al.
PLOS GENETICS (2009)
Influence of Brugia malayi life stages and BmAFII fraction on experimental Leishmania donovani infection in hamsters
P. K. Murthy et al.
ACTA TROPICA (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Computational approaches for fragment optimization
Eric Vangrevelinghe et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2007)
Crystallization of protein-ligand complexes
Anne M. Hassell et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2007)
Direct screening of a dynamic combinatorial library using mass spectrometry
Sally-Ann Poulsen
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2006)
Gatifloxacin derivatives:: Synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase
D Sriram et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis snapshots of the enzyme in action
SS Wang et al.
BIOCHEMISTRY (2006)
Structure-activity relationships by mass spectrometry: identification of novel MMP-3 inhibitors
DA Ockey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Fragment-based drug discovery
DA Erlanson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Crystal structure of tRNA(m1G37)methyltransferase:: insights into tRNA recognition
HJ Ahn et al.
EMBO JOURNAL (2003)
High-throughput crystallography to enhance drug discovery
A Sharff et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Structure-based virtual screening: an overview
PD Lyne
DRUG DISCOVERY TODAY (2002)
A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis
VK Sambandamurthy et al.
NATURE MEDICINE (2002)
SAR by MS: A ligand based technique for drug lead discovery against structured RNA targets
EE Swayze et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
High-throughput crystallography for lead discovery in drug design
TL Blundell et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase
RJ Zheng et al.
BIOCHEMISTRY (2001)
Synergy between combinatorial chemistry and de novo design
AR Leach et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2000)
分享论文
